Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
D031841:Aconitum; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D010672:Phenytoin; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide